CD98hc is a target for brain delivery of biotherapeuticsKylie S. Chew, Mihalis S. Kariolis, Robert C. Wells et al.|Nature Communications|2023Cited by 95
Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIAMichelle E. Pizzo, Y. Joy Yu Zuchero, Edward D. Plowey et al.|Science|2025Cited by 51
Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIAMichelle E. Pizzo, Y. Joy Yu Zuchero, Edward D. Plowey et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 13
Author Correction: CD98hc is a target for brain delivery of biotherapeuticsKylie S. Chew, Mihalis S. Kariolis, Robert C. Wells et al.|Nature Communications|2023Cited by 2
Abstract 207: Dual targeting of DLL4 and VEGF signaling by a novel bispecific antibody inhibits tumor growth and reduces cancer stem cell frequencyWan-Ching Yen, Timothy Hoey, Austin Gurney et al.|Cancer Research|2014Cited by 1